6横田慎一 熊毅雄治 内海光朝.A Pharmacokinetic Study of MCI—186,a novel drug for cerebrovascular disease in elderly and young healthy subjects[J].临床药理,1997,28(3):693-702.
7ADAMAS H,BENDIXEN BH,KAPELLA LJ,et al.Classification of subtype of acute ischemic stroke,1993,24(1):35-41.
8姜卫剑.症状性脑动脉狭窄的血管内支架成形术[J].脑血管病杂志,2003,3(2):78-79.
9BOGOUSSLAVSKY J,BARNETT HJM,FOX A J,et al.Atherosclerotic disease of middle cerebral artery[J].Stroke,1986,17:1112-1120.
1Yoshida H, Kwon AH, Kaibori M, et al. Edarvone prevents iNOS expression by inhibiting its promoter transactivation and mRNA stability in cytokine-stimulated hepatocytes. Nitric Oxide, 2008, 18(2):105-112.
2Nakamura T, Kuroda Y, Yamashita S, et al. Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage. Stroke, 2008, 39(2):463-469.
3Dziedzic T. Clinical significance of acute phase reaction in stroke patients. J Front Biosci, 2008(13):2922-2927.
